Czynnik IX (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Czynnik IX" in Polish language version.

refsWebsite

Global rank Polish rank

13nih.gov

4^th place

7^th place

10doi.org

2^nd place

6^th place

2jbc.org

4,455^th place

6,144^th place

1web.archive.org

1^st place

1books.google.com

3^rd place

27^th place

1benefix.com

low place

1factorix.org

low place

benefix.com

BeneFIX Coagulation Factor IX (Recombinant) Official Site.

books.google.com

Nicholl D.: An Introduction to Genetic Engineering. Wyd. 2. Cambridge University Press, 2002, s. 257. ISBN 978-0-521-00471-8.

doi.org

Di Scipio RG, Kurachi K, Davie EW. Activation of human factor IX (Christmas factor). „J. Clin. Invest.”. 61 (6), s. 1528–1538, 1978. DOI: 10.1172/JCI109073. PMID: 659613. PMCID: PMC372679.
Zhong D, Bajaj MS, Schmidt AE, Bajaj SP. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to twydanie factor. „J. Biol. Chem.”. 277 (5), s. 3622–3631, 2002. DOI: 10.1074/jbc.M111202200. PMID: 11723140.
Wilkinson FH, Ahmad SS, Walsh PN. The factor IXa second epidermal growth factor (EGF₂) domain mediates platelet binding and assembly of the factor X activating complex. „J. Biol. Chem.”. 277 (8), s. 5734–5741, 2002. DOI: 10.1074/jbc.M107753200. PMID: 11714704.
Brandstetter H, Bauer M, Huber R, Lollar P, Bode W. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B. „Proc. Natl. Acad. Sci. U.S.A.”. 92 (21), s. 9796–9800, 1995. DOI: 10.1073/pnas.92.21.9796. PMID: 7568220. PMCID: PMC40889.
Freedman SJ, Furie BC, Furie B, Baleja JD. Structure of the calcium ion-bound γ-carboxyglutamic acid-rich domain of factor IX. „Biochemistry”. 34 (38), s. 12126–12137, 1995. DOI: 10.1021/bi00038a005. PMID: 7547952.
Zogg T, Brandstetter H,. Structural Basis of the Cofactor- and Substrate-Assisted Activation of Human Coagulation Factor IXa. „Structure”. 17 (12), s. 1669–1678, 2009. DOI: 10.1016/j.str.2009.10.011. PMID: 20004170.
Kurachi K, Davie E. Isolation and characterization of a cDNA coding for human factor IX. „Proc Natl Acad Sci USA”. 79 (21), s. 6461–6464, 1982. DOI: 10.1073/pnas.79.21.6461. PMID: 6959130. PMCID: PMC347146.
Simioni P, Tormene D, Tognin G, Gavasso S, Bulato C, Iacobelli NP, Finn JD, Spiezia L, Radu C, Arruda VR. X-linked thrombophilia with a mutant factor IX (factor IX Padua). „N. Engl. J. Med.”. 361 (17), s. 1671–1675, 2009. DOI: 10.1056/NEJMoa0904377. PMID: 19846852.
Rossi M, Jayaram R, Sayeed R. Do patients with haemophilia undergoing cardiac surgery have good surgical outcomes?. „Interact Cardiovasc Thorac Surg”. 13 (3), s. 320–331, 2011. DOI: 10.1510/icvts.2011.272401. PMID: 21712351.

dx.doi.org

RR. Biggs RR. i inni, Christmas Disease, „British Medical Journal”, 4799, 2, 1952, s. 1378–1382, DOI: 10.1136/bmj.2.4799.1378, PMID: 12997790, PMCID: PMC2022306 .

factorix.org

Factor IX Mutation Database. www.factorix.org. [dostęp 2014-06-24].

jbc.org

Zhong D, Bajaj MS, Schmidt AE, Bajaj SP. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to twydanie factor. „J. Biol. Chem.”. 277 (5), s. 3622–3631, 2002. DOI: 10.1074/jbc.M111202200. PMID: 11723140.
Wilkinson FH, Ahmad SS, Walsh PN. The factor IXa second epidermal growth factor (EGF₂) domain mediates platelet binding and assembly of the factor X activating complex. „J. Biol. Chem.”. 277 (8), s. 5734–5741, 2002. DOI: 10.1074/jbc.M107753200. PMID: 11714704.

nih.gov

ncbi.nlm.nih.gov

RR. Biggs RR. i inni, Christmas Disease, „British Medical Journal”, 4799, 2, 1952, s. 1378–1382, DOI: 10.1136/bmj.2.4799.1378, PMID: 12997790, PMCID: PMC2022306 .
Di Scipio RG, Kurachi K, Davie EW. Activation of human factor IX (Christmas factor). „J. Clin. Invest.”. 61 (6), s. 1528–1538, 1978. DOI: 10.1172/JCI109073. PMID: 659613. PMCID: PMC372679.
Taran LD. Factor IX of the blood coagulation system: a review. „Biochemistry Mosc.”. 62 (7), s. 685–693, 1997. PMID: 9331959.
Boland EJ, Liu YC, Walter CA, Herbert DC, Weaker FJ, Odom MW, Jagadeeswaran P. Age-specific regulation of clotting factor IX gene expression in normal and transgenic mice. „Blood”. 86 (6), s. 2198–2205, 1995. PMID: 7662969.
Zhong D, Bajaj MS, Schmidt AE, Bajaj SP. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to twydanie factor. „J. Biol. Chem.”. 277 (5), s. 3622–3631, 2002. DOI: 10.1074/jbc.M111202200. PMID: 11723140.
Wilkinson FH, Ahmad SS, Walsh PN. The factor IXa second epidermal growth factor (EGF₂) domain mediates platelet binding and assembly of the factor X activating complex. „J. Biol. Chem.”. 277 (8), s. 5734–5741, 2002. DOI: 10.1074/jbc.M107753200. PMID: 11714704.
Brandstetter H, Bauer M, Huber R, Lollar P, Bode W. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B. „Proc. Natl. Acad. Sci. U.S.A.”. 92 (21), s. 9796–9800, 1995. DOI: 10.1073/pnas.92.21.9796. PMID: 7568220. PMCID: PMC40889.
Freedman SJ, Furie BC, Furie B, Baleja JD. Structure of the calcium ion-bound γ-carboxyglutamic acid-rich domain of factor IX. „Biochemistry”. 34 (38), s. 12126–12137, 1995. DOI: 10.1021/bi00038a005. PMID: 7547952.
Zogg T, Brandstetter H,. Structural Basis of the Cofactor- and Substrate-Assisted Activation of Human Coagulation Factor IXa. „Structure”. 17 (12), s. 1669–1678, 2009. DOI: 10.1016/j.str.2009.10.011. PMID: 20004170.
Kurachi K, Davie E. Isolation and characterization of a cDNA coding for human factor IX. „Proc Natl Acad Sci USA”. 79 (21), s. 6461–6464, 1982. DOI: 10.1073/pnas.79.21.6461. PMID: 6959130. PMCID: PMC347146.
SA. Taylor, J. Duffin, C. Cameron, J. Teitel i inni. Characterization of the original Christmas disease mutation (cysteine 206→serine): from clinical recognition to molecular pathogenesis. „Thromb Haemost”. 67 (1), s. 63-65, 1992. PMID: 1615485.
Simioni P, Tormene D, Tognin G, Gavasso S, Bulato C, Iacobelli NP, Finn JD, Spiezia L, Radu C, Arruda VR. X-linked thrombophilia with a mutant factor IX (factor IX Padua). „N. Engl. J. Med.”. 361 (17), s. 1671–1675, 2009. DOI: 10.1056/NEJMoa0904377. PMID: 19846852.
Rossi M, Jayaram R, Sayeed R. Do patients with haemophilia undergoing cardiac surgery have good surgical outcomes?. „Interact Cardiovasc Thorac Surg”. 13 (3), s. 320–331, 2011. DOI: 10.1510/icvts.2011.272401. PMID: 21712351.

web.archive.org

Boland EJ, Liu YC, Walter CA, Herbert DC, Weaker FJ, Odom MW, Jagadeeswaran P. Age-specific regulation of clotting factor IX gene expression in normal and transgenic mice. „Blood”. 86 (6), s. 2198–2205, 1995. PMID: 7662969.